Marihuana for Medical Purposes A New Approach. History of Access to Marihuana for Medical Purposes R. v. Parker (Ontario Court of Appeal 2000) The facts.

Slides:



Advertisements
Similar presentations
TECHNO-TONOMY Privacy & Autonomy in a Networked World Learning Module 2: Legislating Privacy: Your Rights.
Advertisements

PRIVACY ACT OF 1974 OVERVIEW. FAIR INFORMATION PRACTICES The Privacy Act is primarily concerned with fair information practices. The Privacy Act is primarily.
Health Products and Food Branch Direction générale des produits de santé et des aliments The Canadian Medical Devices Regulatory Program CESO Conference.
Information for Students MGH Institute of Health Professions Use your down arrow or click your mouse to advance through the presentation.
Confidentiality and HIPAA
The Problem Solvers TM Privacy Rights: Minors and Parents Michael J. Hewitt Marcel Daigle Singleton Urquhart LLP.
Constitutional Law Presentation by: Melissa Weatherbie.
© Information and Privacy Commissioner of Ontario, 2006 Circle of Care Ontario University & College Health Association - May 24, Manuela Di Re Associate.
Hong Kong Privacy Code on Human Resource Management
The Federal Regulator’s Perspective Industrial Railway Safety Conference Fort Saskatchewan, Alberta April 28, 2015.
John Naim, PhD Director Clinical Trials Research Unit
Introduction to the APPs and the OAIC’s regulatory approach Presented by: Este Darin-Cooper Director, Regulation and Strategy May 2015.
The UK Freedom of Information Act – A Practical Guide for Academic Researchers Cambridge Wednesday, 16 February 2011.
FERPA 2008 New regulations enact updates from over a decade of interpretations.
HUMAN RESOURCES ISSUES American University March 9-14, 2003.
EMPLOYMENT LAW CONSIDERATIONS March 16, Difference between being an employer vs. a law enforcement officer Garrity – this case involves employees’
EMPLOYMENT LAW CONSIDERATIONS JULY 13, 2004 Professor Susan Carle.
Click the mouse button or press the space bar to display information. How many people know a lot about their family health history? Why is this important?
Towards a Freedom of Information Law in Qatar Fahad bin Mohammed Al Attiya Executive Chairman, Qatar National Food Security Programme.
MEDICAL MARIHUANA: MUNICIPAL PERSPECTIVE ON LICENSING AND ZONING CHALLENGES Robert Genoway Legal Counsel, City of Mississauga.
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
UNIT 5 AMERICAN GOVERNMENT. LESSON PAGES How do the 4 th and 5 th Amendments protect against unreasonable law enforcement procedures? Objective:
Canada Consumer Product Safety Act (CCPSA)
Canada Consumer Product Safety Act An Overview Graham Stewart Health Canada.
P A R T P A R T Regulation of Business Administrative Agencies The Federal Trade Commission Act and Consumer Protection Laws Antitrust: The Sherman Act.
Clinical Trial Review and Approval: New Regulations and their implications Siddika Mithani, Ph.D Clinical Trials & Special Access Programme Therapeutic.
Nuclearsafety.gc.ca Joint Congress on Medical Imaging and Radiation Sciences May 28, 2015 e-Doc CNSC Administrative Monetary Penalties Overview.
The FPP Test What you (or your students) need to know Flight Training Division Presentation AIA Aviation Week Conference July 2011.
1 Understanding CQC registration Summer Introduction to CQC.
1 Workshop on the Directive 96/61/EC concerning (IPPC) Integrated pollution prevention and control INFRA Public participation & access to environmental.
Data Protection Act & Freedom of Information Simon Mansell Corporate Governance and Information Team.
FleetBoston Financial HIPAA Privacy Compliance Agnes Bundy Scanlan Managing Director and Chief Privacy Officer FleetBoston Financial.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Chapter 43 Administrative Law and Regulatory Agencies
© 2010 Pearson Education, Inc., publishing as Prentice-Hall 1 ADMINISTRATIVE LAW AND REGULATORY AGENCIES © 2010 Pearson Education, Inc., publishing as.
Office of the Office of the Information Commissioner The Irish Freedom of Information Act and the role of the Information Commissioner Sean Garvey Senior.
BC Public Libraries November, 2008 Privacy Principles.
STUDENT JUDICIAL AFFAIRS Balancing the Principals of Natural Justice with Requirements of Privacy Legislation CCSJA March 23, 2006 Harry Davis Deborah.
Rhonda Anderson, RHIA, President  …is a PROCESS, not a PROJECT 2.
Regulatory Regimes Joyce Carr Water Framework Directive Team Scottish Executive.
Key Individual Chapter 2. Purpose of FAIS Consumer protection Professionalize intermediary and advisory services in Financial Services industry Regulate.
Chapter 10 The Criminal Process. A.k.a. Procedural criminal law Two most essential elements of Canadian Criminal Process are: - Truth - Justice.
An Introduction to the Privacy Act Privacy Act 1993 Promotes and protects individual privacy Is concerned with the privacy of information about people.
FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,
Sharing Information (FERPA) FY07 REMS Initial Grantee Meeting December 5, 2007, San Diego, CA U.S. Department of Education, Office of Safe and Drug-Free.
FERPA for the Financial Aid Office NCASFAA Fall Conference November 2012.
Tax Court of Canada THIRD PARTY INFORMATION IN MAKING ASSESSMENT INTERNATIONAL ASSOCIATION OF TAX JUDGES Lucerne, Switzerland September 4, 2015 The Hon.
Introduction to the Australian Privacy Principles & the OAIC’s regulatory approach Privacy Awareness Week 2016.
Health and Social Care Act 2008 Registration and Compliance Monitoring Maggie Hannelly Compliance Manager Bedfordshire 6 December 2010.
HEALTH INFORMATION & PATIENT SAFETY BILL 2015 Dr Kieran Doran, Solicitor Senior Healthcare Ethics Lecturer School of Medicine University College Cork 1.
Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur.
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
Off-label Use.
ClinicalTrials.gov Requirements
Kids' legal rights in medical care, your obligations and risk minimisation 27 April 2017.
Public Health Implications of
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
The HIPAA Privacy Rule: Implications for Medical Research
Data protection issues in regulatory investigations
HCS 430 Education for Service-- tutorialrank.com
Medical marijuana: legal implications
Running an external review of a Queensland government RTI decision
May 8, 2018 Nova Scotia Law Enforcement Perspective
Enforcement and Policy Challenges in Health Information Privacy
Applying for a Licence Under the Cannabis Act and its Regulations
Chapter 43 Administrative Law and Regulatory Agencies
The Freedom of Information and Data Protection Legislation An Overview
PROPOSED AMENDMENTS TO marijuana regulations
School Searches and You
Access to Cannabis for Medicinal and Research Purposes
Presentation transcript:

Marihuana for Medical Purposes A New Approach

History of Access to Marihuana for Medical Purposes R. v. Parker (Ontario Court of Appeal 2000) The facts The Charter The Remedy The MMAR- 2001

Marihuana Medical Access Regulations (2001)  No valid medical exemption = No valid criminal prohibition on possession (and possibly production)  Individuals can: o Grow for themselves (PUPL) o Grow for one other person (DPPL) o Buy from Health Canada (introduced after Hitzig, 2003)  Need a medical declaration from a doctor; OCA upheld this requirement in Mernagh  No maximum daily dosage/possession cap in MMAR

Unintentional Consequences of the MMAR  Exponential growth in the program: 2002 = 477 participants April 16, 2013 = 29,888 participants—at time of repeal, approximately 38,000 participants 12% access HC marihuana supply 5% indicate HC supply but do not purchase 67% produce for themselves under a PUPL 16% obtain marihuana from a DPPL  Avg. daily amount approx grams (December 12, 2013) 18g/day is approx. 88 plants indoors under the MMAR formula  Ongoing Charter challenges What is the scope of the “right” to medical marihuana and how has it evolved?

Reform Objectives  Treat marihuana as much as possible like other drugs/narcotics  Reduce risks to public health, security, safety of Canadians by eliminating personal production  Improve quality for the individual by regulating sanitation and production practices for medical marihuana as with drugs in the FDA  Restore Health Canada to role of regulator

MMPR Approach: Licensed producers  LP Notification of local authorities (municipality, police, fire officials Sections 38, 39, 40) Upon application and any change in status to licence LP to provide certain information to Canadian police force in course of an investigation (s. 101) LP Notification to licensing authority re health care practitioner (Section 102)  Minister authorised to provide certain information to Canadian police force, to customs officers to International Narcotics Control Board (Sections )  Physical security requirements for both perimeter and areas with cannabis (Sections 41-51)  Security clearances for key personnel (Sections ) Designated drug and criminal offences Assessment of risks to the integrity of control of cannabis, e.g. diversion to illicit markets  Good production practices (Sections 52-63) Similar to those for natural health products, food and drugs under the Food and Drug Regulations Sanitation, quality controls, consistency of THC and CBD  No advertising to the general public Ss. 3, 9 of Food and Drugs Act - no false or misleading ads, e.g. for a specific therapeutic use without evidence S.70 Narcotic Control Regulations  Inspections: per MMPR s. 9 and CDSA, s. 31

LP: Activities and Requirements Dried marihuana only (Smith on appeal to the SCC) Indoor grow only; no dwelling houses MMPR does not include zoning requirements: but LPs to notify local authorities on application, issuance, renewal, amendment, suspension, reinstatement or revocation of the licence Notifications must be addressed to a senior official of the local authority (municipality, fire and law enforcement)—specify activities and address of the site

Compliance and Enforcement Inspection  Pre-licence inspection  Compliance Inspections increased number of dedicated inspections within the first year to establish a compliance and enforcement regime  Non-compliance and corrective action plans MMPR provide for suspensions, revocations and recalls  Reporting LPs must submit reports to HC Information analysed and fed into ongoing C & E planning

Allard: MMPR Challenge and Injunction Order  Trial 3 weeks starting February 23, 2015, challenging: Marihuana production by licensed producers only o Under MMPR= no more growing in dwelling houses; indoor growing only o Under MMPR= inspections for compliance and enforcement, security, quality Restriction to production and distribution of dried marihuana, and distribution by mail/courrier Caps on possession Indoor cultivation only

Allard Interlocutory Injunction Order Order issued March 21, appeal/cross appeal to be heard November 24, 2014 o MMAR repealed March 31, 2014; MMPR in effect o But, certain ATPs and PUPL/DPPLs extended under “frozen” terms, so marihuana growing in dwelling houses continues by virtue of “Allard order” o 150 gram possession cap Individuals must have held a valid Authorizations to Possess under the MMAR on March 21, Individuals must have held a valid Personal-Use Production Licence or Designated-Person Production Licence under the MMAR on, or after, September 30, 2013, where there is also an associated valid ATP as of March 21, Individuals with a medical need who do not fall within the scope of this court order and who have the support of a licensed healthcare practitioner may register with a licensed producer under the MMPR.

Information Sharing In disclosing personal information, HC is guided by the Charter of Rights and Freedoms & the Privacy Act Both seek to uphold balance between the right to privacy and Canada’s interest in advancing its goals (in HC/CDSA context =protect public health and safety) Charter s. 8 provides everyone has the right to be secure against unreasonable search and seizure; this guarantee protects against state intrusion into a “reasonable expectation of privacy” in one’s person, surroundings and information. The “totality of the circumstances” must be considered to determine where there is a reasonable expectation of privacy. There must be reasonable lawful authority for an intrusion (common law or legislation and must be reasonable: that is intrude no more than necessary & proportional). The Privacy Act protects information about an identifiable individual that is recorded in any form and information that many not on its face identify an individual, but could be linked with other information to identify an individual. Information can be released on consent of the individual or per s. 8 exemptions from the application of the Act MMPR information disclosure provisions are designed to allow disclosure of information in compliance with both the Charter and the PA; HC makes case by case decisions re requests for information sharing

Resources Marihuana for Medical Purposes Regulations MMPR and Regulatory Impact Statement at CG II June 19, Health Canada Website: Medical use of Marihuana and Injunction Order Information for Health Care Professionals Directive on Physical Security Requirements for Controlled Substances eng.php Guidance Document: Building and Production Security Requirements for Marihuana for Medical Purposes Frequently Asked Questions